A Phase 1, Single Ascending Oral Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP3700 in Healthy Male Subjects, Including a Drug-drug Interaction Part With Itraconazole
Phase of Trial: Phase I
Latest Information Update: 07 Nov 2014
Price : $35 *
At a glance
- Drugs ASP 3700 (Primary) ; Itraconazole
- Indications Osteoarthritis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Astellas Pharma
- 29 Oct 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Sep 2014 Planned End Date changed from 1 Sep 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov record.
- 24 Sep 2014 Planned primary completion date changed from 1 Sep 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov record.